GlassScriptPhysician profile
John A Scanland
NPI 1649380890
$2,920.32
in general payments reported to CMS, 2019-2025
13 companies · $763 in 2025
The $763 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $53.55 · 2021: $66.81 · 2022: $475 · 2023: $595 · 2024: $714 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,072.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $755.04 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $747.89 | 2019-2024 | Puraply |
| Smith+Nephew, INC. | $571.17 | 2019-2025 | Stravix, Grafix Pl, Stravix Pl |
| Integra Lifesciences Corporation | $349.44 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Teva Pharmaceuticals USA, INC. | $115.54 | 2025 | Austedo Xr |
| Comsort, INC | $100.00 | 2019 | |
| Stryker Corporation | $93.97 | 2022 | |
| Globus Medical, INC. | $77.97 | 2025 | Senza |
| Musculoskeletal Transplant Foundation INC. | $32.88 | 2019 | |
| Nevro Corp. | $23.86 | 2024 | Senza |
| Abbott Laboratories | $21.20 | 2025 | Proclaim |
| Progenacare Global, LLC | $16.60 | 2024 | |
| Tactile Systems Technology INC | $14.76 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scanland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.